Found: 9
Select item for more details and to access through your institution.
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919899850
- By:
- Publication type:
- Article
Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens.
- Published in:
- Cancers, 2014, v. 6, n. 3, p. 1753, doi. 10.3390/cancers6031753
- By:
- Publication type:
- Article
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49601-3
- By:
- Publication type:
- Article
Dose finding study of erlotinib combined to capecitabine and irinotecan in pretreated advanced colorectal cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 67, doi. 10.1007/s00280-008-0852-1
- By:
- Publication type:
- Article
Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric Adenocarcinoma.
- Published in:
- Oncology, 2006, v. 71, n. 5/6, p. 341, doi. 10.1159/000108575
- By:
- Publication type:
- Article
Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 230, doi. 10.1093/oncolo/oyad007
- By:
- Publication type:
- Article
Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab.
- Published in:
- Medical Oncology, 2012, v. 29, n. 4, p. 2838, doi. 10.1007/s12032-011-0132-5
- By:
- Publication type:
- Article
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189848
- By:
- Publication type:
- Article